Literature DB >> 20696252

Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta.

Joseph M Wallace1, Bradford G Orr, Joan C Marini, Mark M Banaszak Holl.   

Abstract

Bone has a complex hierarchical structure that has evolved to serve structural and metabolic roles in the body. Due to the complexity of bone structure and the number of diseases which affect the ultrastructural constituents of bone, it is important to develop quantitative methods to assess bone nanoscale properties. Autosomal dominant Osteogenesis Imperfecta results predominantly from glycine substitutions (80%) and splice site mutations (20%) in the genes encoding the α1 or α2 chains of Type I collagen. Genotype-phenotype correlations using over 830 collagen mutations have revealed that lethal mutations are located in regions crucial for collagen-ligand binding in the matrix. However, few of these correlations have been extended to collagen structure in bone. Here, an atomic force microscopy-based approach was used to image and quantitatively analyze the D-periodic spacing of Type I collagen fibrils in femora from heterozygous (Brtl/+) mice (α1(I)G349C), compared to wild type (WT) littermates. This disease system has a well-defined change in the col1α1 allele, leading to a well characterized alteration in collagen protein structure, which are directly related to altered Type I collagen nanoscale morphology, as measured by the D-periodic spacing. In Brtl/+ bone, the D-periodic spacing shows significantly greater variability on average and along the length of the bone compared to WT, although the average spacing was unchanged. Brtl/+ bone also had a significant difference in the population distribution of collagen D-period spacings. These changes may be due to the mutant collagen structure, or to the heterogeneity of collagen monomers in the Brtl/+ matrix. These observations at the nanoscale level provide insight into the structural basis for changes present in bone composition, geometry and mechanical integrity in Brtl/+ bones. Further studies are necessary to link these morphological observations to nanoscale mechanical integrity.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696252      PMCID: PMC2997118          DOI: 10.1016/j.jsb.2010.08.003

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  29 in total

1.  A transmission electron microscope study using vitrified ice sections of predentin: structural changes in the dentin collagenous matrix prior to mineralization.

Authors:  E Beniash; W Traub; A Veis; S Weiner
Journal:  J Struct Biol       Date:  2000-12       Impact factor: 2.867

2.  Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.

Authors:  F Rauch; R Travers; A M Parfitt; F H Glorieux
Journal:  Bone       Date:  2000-06       Impact factor: 4.398

3.  A demineralization procedure for immunohistopathological use. EDTA treatment preserves lymphoid cell surface antigens.

Authors:  R Jonsson; A Tarkowski; L Klareskog
Journal:  J Immunol Methods       Date:  1986-04-03       Impact factor: 2.303

4.  Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta.

Authors:  P Sarathchandra; F M Pope; S Y Ali
Journal:  Calcif Tissue Int       Date:  1999-11       Impact factor: 4.333

5.  Twisted plywood architecture of collagen fibrils in human compact bone osteons.

Authors:  M M Giraud-Guille
Journal:  Calcif Tissue Int       Date:  1988-03       Impact factor: 4.333

6.  Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.

Authors:  Francis H Glorieux; Leanne M Ward; Frank Rauch; Ljiljana Lalic; Peter J Roughley; Rose Travers
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

7.  Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV mice.

Authors:  A Forlino; F D Porter; E J Lee; H Westphal; J C Marini
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

8.  The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Authors:  Daniela S Gerhard; Lukas Wagner; Elise A Feingold; Carolyn M Shenmen; Lynette H Grouse; Greg Schuler; Steven L Klein; Susan Old; Rebekah Rasooly; Peter Good; Mark Guyer; Allison M Peck; Jeffery G Derge; David Lipman; Francis S Collins; Wonhee Jang; Steven Sherry; Mike Feolo; Leonie Misquitta; Eduardo Lee; Kirill Rotmistrovsky; Susan F Greenhut; Carl F Schaefer; Kenneth Buetow; Tom I Bonner; David Haussler; Jim Kent; Mark Kiekhaus; Terry Furey; Michael Brent; Christa Prange; Kirsten Schreiber; Nicole Shapiro; Narayan K Bhat; Ralph F Hopkins; Florence Hsie; Tom Driscoll; M Bento Soares; Tom L Casavant; Todd E Scheetz; Michael J Brown-stein; Ted B Usdin; Shiraki Toshiyuki; Piero Carninci; Yulan Piao; Dawood B Dudekula; Minoru S H Ko; Koichi Kawakami; Yutaka Suzuki; Sumio Sugano; C E Gruber; M R Smith; Blake Simmons; Troy Moore; Richard Waterman; Stephen L Johnson; Yijun Ruan; Chia Lin Wei; S Mathavan; Preethi H Gunaratne; Jiaqian Wu; Angela M Garcia; Stephen W Hulyk; Edwin Fuh; Ye Yuan; Anna Sneed; Carla Kowis; Anne Hodgson; Donna M Muzny; John McPherson; Richard A Gibbs; Jessica Fahey; Erin Helton; Mark Ketteman; Anuradha Madan; Stephanie Rodrigues; Amy Sanchez; Michelle Whiting; Anup Madari; Alice C Young; Keith D Wetherby; Steven J Granite; Peggy N Kwong; Charles P Brinkley; Russell L Pearson; Gerard G Bouffard; Robert W Blakesly; Eric D Green; Mark C Dickson; Alex C Rodriguez; Jane Grimwood; Jeremy Schmutz; Richard M Myers; Yaron S N Butterfield; Malachi Griffith; Obi L Griffith; Martin I Krzywinski; Nancy Liao; Ryan Morin; Ryan Morrin; Diana Palmquist; Anca S Petrescu; Ursula Skalska; Duane E Smailus; Jeff M Stott; Angelique Schnerch; Jacqueline E Schein; Steven J M Jones; Robert A Holt; Agnes Baross; Marco A Marra; Sandra Clifton; Kathryn A Makowski; Stephanie Bosak; Joel Malek
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

9.  Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.

Authors:  Natalia V Kuznetsova; Antonella Forlino; Wayne A Cabral; Joan C Marini; Sergey Leikin
Journal:  Matrix Biol       Date:  2004-05       Impact factor: 11.583

10.  Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength.

Authors:  Kenneth M Kozloff; Angela Carden; Clemens Bergwitz; Antonella Forlino; Thomas E Uveges; Michael D Morris; Joan C Marini; Steven A Goldstein
Journal:  J Bone Miner Res       Date:  2004-01-12       Impact factor: 6.741

View more
  27 in total

Review 1.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

2.  Variation in type I collagen fibril nanomorphology: the significance and origin.

Authors:  Ming Fang; Mark M Banaszak Holl
Journal:  Bonekey Rep       Date:  2013-08-21

3.  Studies of chain substitution caused sub-fibril level differences in stiffness and ultrastructure of wildtype and oim/oim collagen fibers using multifrequency-AFM and molecular modeling.

Authors:  Tao Li; Shu-Wei Chang; Naiara Rodriguez-Florez; Markus J Buehler; Sandra Shefelbine; Ming Dao; Kaiyang Zeng
Journal:  Biomaterials       Date:  2016-08-24       Impact factor: 12.479

4.  Collagen Fibril Ultrastructure in Mice Lacking Discoidin Domain Receptor 1.

Authors:  Jeffrey R Tonniges; Benjamin Albert; Edward P Calomeni; Shuvro Roy; Joan Lee; Xiaokui Mo; Susan E Cole; Gunjan Agarwal
Journal:  Microsc Microanal       Date:  2016-06       Impact factor: 4.127

5.  Effect of CNT on collagen fiber structure, stiffness assembly kinetics and stem cell differentiation.

Authors:  Taeyoung Kim; Indumathi Sridharan; Bofan Zhu; Joseph Orgel; Rong Wang
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2015-01-07       Impact factor: 7.328

6.  Nanoscale structure of type I collagen fibrils: quantitative measurement of D-spacing.

Authors:  Blake Erickson; Ming Fang; Joseph M Wallace; Bradford G Orr; Clifford M Les; Mark M Banaszak Holl
Journal:  Biotechnol J       Date:  2012-10-24       Impact factor: 4.677

7.  Bone mineral properties in growing Col1a2(+/G610C) mice, an animal model of osteogenesis imperfecta.

Authors:  Marco Masci; Min Wang; Laurianne Imbert; Aileen M Barnes; Lyudmila Spevak; Lyudmila Lukashova; Yihe Huang; Yan Ma; Joan C Marini; Christina M Jacobsen; Matthew L Warman; Adele L Boskey
Journal:  Bone       Date:  2016-04-13       Impact factor: 4.398

8.  Bone cell-independent benefits of raloxifene on the skeleton: a novel mechanism for improving bone material properties.

Authors:  Maxime A Gallant; Drew M Brown; Max Hammond; Joseph M Wallace; Jiang Du; Alix C Deymier-Black; Jonathan D Almer; Stuart R Stock; Matthew R Allen; David B Burr
Journal:  Bone       Date:  2014-01-24       Impact factor: 4.398

9.  Multiscale analysis of morphology and mechanics in tail tendon from the ZDSD rat model of type 2 diabetes.

Authors:  Armando Diaz Gonzalez; Maxime A Gallant; David B Burr; Joseph M Wallace
Journal:  J Biomech       Date:  2013-12-06       Impact factor: 2.712

10.  Effects of tissue hydration on nanoscale structural morphology and mechanics of individual Type I collagen fibrils in the Brtl mouse model of Osteogenesis Imperfecta.

Authors:  Arika D Kemp; Chad C Harding; Wayne A Cabral; Joan C Marini; Joseph M Wallace
Journal:  J Struct Biol       Date:  2012-10-04       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.